119-hr1931

HR
✓ Complete Data

Access to Pediatric Technologies Act of 2025

Login to track bills
Introduced:
Mar 6, 2025
Policy Area:
Health

Bill Statistics

4
Actions
15
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text

AI Summary

No AI Summary Available

Click the button above to generate an AI-powered summary of this bill using Claude.

The summary will analyze the bill's key provisions, impact, and implementation details.

Latest Action

Mar 6, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Actions (4)

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Type: IntroReferral | Source: House floor actions | Code: H11100
Mar 6, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Type: IntroReferral | Source: House floor actions | Code: H11100
Mar 6, 2025
Introduced in House
Type: IntroReferral | Source: Library of Congress | Code: Intro-H
Mar 6, 2025
Introduced in House
Type: IntroReferral | Source: Library of Congress | Code: 1000
Mar 6, 2025

Subjects (1)

Health (Policy Area)

Text Versions (1)

Introduced in House

Mar 6, 2025

Full Bill Text

Length: 5,462 characters Version: Introduced in House Version Date: Mar 6, 2025 Last Updated: Nov 14, 2025 6:11 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1931 Introduced in House

(IH) ]

<DOC>

119th CONGRESS
1st Session
H. R. 1931

To amend title XVIII of the Social Security Act to facilitate patient
access to certain pediatric technologies.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

March 6, 2025

Mr. Joyce of Pennsylvania (for himself and Mrs. Trahan) introduced the
following bill; which was referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means, for a
period to be subsequently determined by the Speaker, in each case for
consideration of such provisions as fall within the jurisdiction of the
committee concerned

_______________________________________________________________________

A BILL

To amend title XVIII of the Social Security Act to facilitate patient
access to certain pediatric technologies.

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.

This Act may be cited as the ``Access to Pediatric Technologies Act
of 2025''.
SEC. 2.

(a) In General.--
Section 1848 of the Social Security Act (42 U.
1395w-4) is amended by adding at the end the following new subsection:
``

(u) Facilitating Access to Pediatric Technologies.--
``

(1) In general.--For each qualifying pediatric technology
(as defined in paragraph

(4) ) furnished on or after January 1,
2026, the Secretary shall, upon receipt of a manufacturer
request under paragraph

(3) , establish national relative value
units under the physician fee schedule established under this
section, to the extent no such national relative value units
have been established for such qualifying pediatric technology
under such fee schedule.
``

(2) Payment methodology.--The Secretary shall establish
national relative value units for a qualifying pediatric
technology under this subsection--
``
(A) in accordance with the payment methodology
established under this section and applicable
regulations; and
``
(B) using available data related to the
qualifying pediatric technology, which may include
applicable contractor pricing information, claims data,
time and motion studies, invoice information, or other
information used by the Secretary in establishing
payment rates.
``

(3) Implementation.--
``
(A) In general.--Upon written request to the
Secretary from the manufacturer of a qualifying
pediatric technology, the Secretary shall establish
national relative value units under paragraph

(1) through the annual rulemaking process for the physician
fee schedule established under this section, in
accordance with the timeline described in subparagraph
(B) .
``
(B) Timeline.--
``
(i) In the case where the Secretary
receives a request under this paragraph on or
before May 1 of a given year from a
manufacturer with respect to a qualifying
pediatric technology of the manufacturer, the
Secretary shall establish national relative
value units for the qualifying pediatric
technology in the rulemaking process during
that year for the physician fee schedule
established under this section.
``
(ii) In the case where the Secretary
receives a request under this paragraph after
May 1 of a given year from a manufacturer with
respect to a qualifying pediatric technology of
the manufacturer, the Secretary shall establish
national relative value units for the
qualifying pediatric technology in the
rulemaking process during the following year
for the physician fee schedule established
under this section.
``
(C) Content of manufacturer requests.--A
manufacturer submitting a request under paragraph with
respect to a qualifying pediatric technology of the
manufacturer shall include in such request information
to verify that the technology is a qualifying pediatric
technology and to allow the Secretary to establish
national relative value units for such technology,
including (to the extent available) contractor pricing
information, claims data, time and motion studies,
invoice information, or other relevant information.
``

(4) Qualifying pediatric technology defined.--In this
subsection, the term `qualifying pediatric technology' means a
medical device that is--
``
(A) covered under this title;
``
(B) approved, cleared, or authorized under
section 510 (k) , 513 (f) (2) , or 515 of the Federal Food, Drug, and Cosmetic Act (21 U.

(k) , 513

(f)

(2) , or 515 of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C. 360

(k) , 360c

(f)

(2) ,
360e);
``
(C) described by a temporary Level I HCPCS Code
intended for emerging technologies, services, or
procedures; and
``
(D)
(i) used as part of a procedure predominantly
performed on pediatric patients; or
``
(ii) has otherwise been specifically designed for
safe and effective use in pediatric populations.
``

(5) Rule of construction.--Nothing in this subsection
shall be construed to require coverage of a qualifying
pediatric technology under this title or alter the requirements
of
section 1862 (a) (1) (A) .

(a)

(1)
(A) .''.
<all>